Current FDA-Related Drug Information: Approvals, Submission, and Important LabelingChanges for US Marketed Pharmaceuticals.

This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at ude.usw@rekab.lainad. Table 1. New drugs approved by the US Food and Drug Administration (FDA): March 16, 2014 through April 15, 2014 Table 2. New dosage forms and indications approved by the FDA: March 16, 2014 through April 15, 2014 Table 3. Agents pending FDA approval: March 16, 2014 through April 15, 2014 Table 4. New drug/biologics license applications filed by manufacturer: March 16, 2014 through April 15, 2014 Table 5. Supplemental applications filed by manufacturer: March 16, 2014 through April 15, 2014 Table 6. Significant labeling changes or “Dear Health Professional” letters related to safetya